Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Journal of Medical Case Reports
Published in: Journal of Medical Case Reports 1/2022

Open Access 01-12-2022 | Magnetic Resonance Imaging | Case report

Acute respiratory distress syndrome following administration of gadolinium contrast agent: a case report

Authors: Eduardo Atsushi Osawa, Juliana Fernandez Fernandes Kleiman, Alexandre Toledo Maciel

Published in: Journal of Medical Case Reports | Issue 1/2022

Login to get access

Abstract

Background

Gadolinium-based contrast agents are used extensively in magnetic resonance imaging to assist diagnosis of medical conditions. Despite their documented safety profile, severe adverse events do occur, and their documentation may serve to raise the awareness of the medical community.

Case presentation

We report the case of a 15-year-old white Latin American female patient admitted to the intensive care unit for acute respiratory distress syndrome following administration of gadolinium. She did not have rash or tongue swelling but developed hypotension responsive to fluid administration and severe hypoxemia. Chest computed tomography revealed bilateral pulmonary compromise with multiple confluent consolidations. She received methylprednisolone and noninvasive ventilatory support including bilevel positive airway pressure ventilation and high-flow nasal cannula, and underwent a rapid recovery.

Conclusion

Gadolinium-based contrast agent-induced acute respiratory distress syndrome, albeit rare, should be included in the differential diagnosis of respiratory failure shortly after magnetic resonance imaging, which is nowadays a frequent diagnostic procedure, potentially increasing the awareness of this serious complication.
Literature
1.
Thompson BT, Chambers RC, Liu KD. Acute respiratory distress syndrome. N Engl J Med. 2017;377(6):562–72.CrossRefPubMed
2.
McDonald JS, Hunt CH, Kolbe AB, Schmitz JJ, Hartman RP, Maddox DE, et al. acute adverse events following gadolinium-based contrast agent administration: a single-center retrospective study of 281 945 injections. Radiology. 2019;292(3):620–7.CrossRefPubMed
3.
Herborn CU, Honold E, Wolf M, Kemper J, Kinner S, Adam G, et al. Clinical safety and diagnostic value of the gadolinium chelate gadoterate meglumine (Gd-DOTA). Invest Radiol. 2007;42(1):58–62.CrossRefPubMed
4.
Weinreb JC, Rodby RA, Yee J, Wang CL, Fine D, McDonald RJ, et al. Use of intravenous gadolinium-based contrast media in patients with kidney disease: consensus statements from the American College of Radiology and the National Kidney Foundation. Radiology. 2021;298(1):28–35.CrossRefPubMed
5.
Granata V, Cascella M, Fusco R, dell’Aprovitola N, Catalano O, Filice S, et al. Immediate adverse reactions to gadolinium-based MR contrast media: a retrospective analysis on 10,608 examinations. Biomed Res Int. 2016;2016:3918292.CrossRefPubMedPubMedCentral
6.
Murphy KP, Szopinski KT, Cohan RH, Mermillod B, Ellis JH. Occurrence of adverse reactions to gadolinium-based contrast material and management of patients at increased risk: a survey of the American Society of Neuroradiology Fellowship Directors. Acad Radiol. 1999;6(11):656–64.CrossRefPubMed
7.
Forsting M, Palkowitsch P. Prevalence of acute adverse reactions to gadobutrol—a highly concentrated macrocyclic gadolinium chelate: review of 14,299 patients from observational trials. Eur J Radiol. 2010;74(3):e186–92.CrossRefPubMed
8.
Lee-Chiong T Jr, Matthay RA. Drug-induced pulmonary edema and acute respiratory distress syndrome. Clin Chest Med. 2004;25(1):95–104.CrossRefPubMed
9.
Bakowitz M, Bruns B, McCunn M. Acute lung injury and the acute respiratory distress syndrome in the injured patient. Scand J Trauma Resusc Emerg Med. 2012;20:54.CrossRefPubMedPubMedCentral
10.
Gupta N, Davidson J, Li A. Acute respiratory distress syndrome due to gadolinium administration. J Intensive Care Soc. 2013;14(2):159–62.CrossRef
11.
Kerget B, Aksakal A, Afsin DE, Araz O, Ucar EY, Akgun M, et al. Acute respiratory distress syndrome after the use of gadolinium contrast agent. Respir Med Case Rep. 2018;25:336–8.PubMedPubMedCentral
12.
Nguyen C, Pham T. Non-cardiogenic pulmonary oedema following the use of gadolinium-based contrast medium: a case report. J Crit Care Med (Targu Mures). 2020;6(3):181–5.CrossRef
13.
Lee Y, Chung TY, Liu HC. A rare case of acute respiratory distress syndrome caused by use of gadolinium-based magnetic resonance imaging contrast media. Respirol Case Rep. 2019;7(8):e00483.CrossRefPubMedPubMedCentral
14.
Lucas A, Mohan G, Winkler A, Gardner K, Whalen M. Acute lung injury following gadolinium contrast: a case report. J Emerg Crit Care Med. 2021;5(18):1–6.
15.
Acharya S, Anwar S, Madala S, Thapa S, Maroun R. Delayed anaphylaxis due to gadolinium—a rare clinical scenario. Radiol Case Rep. 2021;16(9):2522–5.CrossRefPubMedPubMedCentral
16.
Kato K, Fujimoto S, Inukai S, Takatsu H, Kono Y, Kasai K. Late-onset acute respiratory distress syndrome induced by a gadolinium-based contrast agent. Respir Med Case Rep. 2020;29:100990.PubMed
17.
Demirhan A, Yasar Tekelioglu U, Akkaya A, Dagistan E, Suzi Ayhan S, Ozturk S, et al. Magnetic resonance imaging contrast agent related pulmonary edema: a case report. Eur Rev Med Pharmacol Sci. 2012;16(Suppl 4):110–2.PubMed
18.
Park J, Byun IH, Park KH, Lee JH, Nam EJ, Park JW. Acute respiratory distress syndrome after the use of gadolinium contrast media. Yonsei Med J. 2015;56(4):1155–7.CrossRefPubMedPubMedCentral
19.
Guru PK, Bohman JK, Fleming CJ, Tan HL, Sanghavi DK, De Moraes AG, et al. Severe acute cardiopulmonary failure related to gadobutrol magnetic resonance imaging contrast reaction: successful resuscitation with extracorporeal membrane oxygenation. Mayo Clin Proc. 2016;91(3):362–6.CrossRefPubMed
20.
Cardona V, Ansotegui IJ, Ebisawa M, El-Gamal Y, Fernandez Rivas M, Fineman S, et al. World Allergy Organization anaphylaxis guidance 2020. World Allergy Organ J. 2020;13(10):100472.CrossRefPubMedPubMedCentral
Metadata
Title
Acute respiratory distress syndrome following administration of gadolinium contrast agent: a case report
Authors
Eduardo Atsushi Osawa
Juliana Fernandez Fernandes Kleiman
Alexandre Toledo Maciel
Publication date
01-12-2022
Publisher
BioMed Central
Published in
Journal of Medical Case Reports / Issue 1/2022
Electronic ISSN: 1752-1947
DOI
https://doi.org/10.1186/s13256-022-03643-w

Other articles of this Issue 1/2022

Journal of Medical Case Reports 1/2022 Go to the issue

Case report

Nontypical presentation of a common disease: a case report

Case report

Reversible anomia and cerebral venous thrombosis: a case report and review of the literature

Case report

Transitory ischemic attack associated with a rare fenestration of the cervical segment of the internal carotid artery: a case report

Case report

Management of giant osteoma in the mandible associated with minor trauma: a case report

Case report

Presumed Bietti crystalline dystrophy with optic nerve head drusen: a case report

Case report

Euglycemic diabetic ketoacidosis induced by sodium-glucose cotransporter 2 inhibitor in the setting of prolonged fasting: a case report